Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of HS-20094 Evaluating Weight Loss in Obese and Overweight Chinese Subjects
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Summary
This is a study of HS-20094 in participants with overweight and obesity. The main purpose is to learn more about how HS-20094 affects body weight. The study period including 4-12 weeks dose titration and 12-20 weeks maintain treatment and 6 weeks follow up.
Official title: A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of HS-20094 in Overweight and Obese Subjects
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2023-10-16
Completion Date
2024-08-13
Last Updated
2026-06-04
Healthy Volunteers
Yes
Conditions
Interventions
HS-20094
Administered SC
Placebo
Administered SC
Locations (2)
the Fourth Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China
The Fourth Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China